Professional Memberships:

• American Association for Anatomy (AAA) (2020–present)
• Society for Craniofacial Genetics and Developmental Biology (SCGDB) (2020–present)
• International Society for Cell & Gene Therapy (ISCT) (2016–present)
• International Society for Stem Cell Research (ISSCR) (2013–present)
• American Thoracic Society (ATS) (2010–present)
• Society for Biological Engineering (SBE) (2008–present)
• The American Society for Cell Biology (ASCB) (2004–present)
• American Chemical Society (ACS) (2003–present)
• The Society for In Vitro Biology (2001–2006)
• European Society for Animal Cell Technology (ESACT) (2001–present)

Presentations:

• "The Evolving Global Landscape of Unproven Cell-based Products and Services" Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases; University of Vermont; Direct‐to‐Consumer Cell‐based Interventions for Respiratory Diseases: Stratagems and Countermeasures (2021)
• "Navigating the Landscape of Unproven Cell-Based Products and Services" Massachusetts Association of Blood Banks (MABB) seminar series; Massachusetts Association of Blood Banks; Massachusetts Association of Blood Banks (2020)
• "From embryonic development to pluripotent stem cell-derived lung primordial progenitors" Hastings Center for Pulmonary Research Seminar Series; University of Southern California; Hastings Center for Pulmonary Research (2020)
• "Part 3: Ethics and Business Practices" Potential COVID-19 Treatments Using Cell Therapies; ARM-ARM Foundation-ISCT Webinar (2020)
• "The ISCT PTF: Vision and Goals, 2020-22" ISCT 2020 Paris Virtual Conference; ; Emerging Issues in Unproven Cell Therapies (2020)
• "Fidelity of Pluripotent Stem Cell-Derived Progenitors: Lessons from Foregut Derivatives" ; Rutgers School of Dental Medicine; Oral Biology Department (2019)
• "Fidelity of Pluripotent Stem Cell-Derived Progenitors: Lessons from Foregut Derivatives" ; University of Pittsburgh; Department of Chemical and Petroleum Engineering (2019)
• "Impact of Unproven Cellular Products on the Field" FDA Cell Therapy Liaison Meeting (2019)
• "Fidelity of Pluripotent Stem Cell-Derived Progenitors: Lessons from Foregut Derivatives" ; University at Buffalo; Department of Oral Biology (2019)
• "From Embryonic Development to Pluripotent Stem Cell-Derived Lung and Thyroid Progenitors" ; University at Buffalo; Department of Chemical and Biological Engineering (2019)
• "Marketing of Unproven Stem Cell Interventions: Regulatory, Ethical, and Scientific Issues" CELL-MET Professional Development Day; Boston University; Engineering Research Center (2019)
• "Epithelial Progenitor Heterogeneity in Lung Development" Research on Tap: Medicine in the Molecular Era: Single Cell Sequencing; Boston University School of Medicine (2018)
• "Stem Cell Medical Tourism" Annual Meeting of the American Thoracic Society; ; Meet the Professor Seminar: The stem cell niche: Applications in pulmonary diseases (2018)
• "Unproven Stem Cell Interventions for Respiratory Diseases" Annual Meeting of the American Thoracic Society; ; Human Lung Development: New Tools and Therapeutic Strategies (2018)
• "Biomechanical Determinants of Lung Cell Fate: From Embryonic Development to Pluripotent Stem Cell-Derived Progenitors" ; BU Biomedical Engineering Department; Cell and Tissue Mechanics Laboratory (2017)
• "A Note of Caution in Stem Cell Therapies: Separating the Wheat from the Chaff" Annual Meeting of the American Thoracic Society; ; What, When, Where: Clearing the Air on Stem Cell Therapies In Pulmonary Diseases (2016)
• "Defining the Identity of Lung Epithelial Primordial Progenitors" ; Boston University School of Medicine; Computational Medicine Section (2014)
• "Lung/thyroid specification of ESC-derived anterior foregut through transient expression of Nkx2-1" The Lung Epithelium in Health and Disease; FASEB (2014)
• "Understanding Fate Decisions in Embryonic Lung Progenitors" ; Boston University School of Medicine; Genetics and Genomics Graduate Program (2013)
• "Defining the identity of lung primordial progenitors" Stem Cells and Cell Therapies in Lung Biology and Lung Diseases (2013)
• "In Vitro and In Vivo Studies of Primordial Lung Progenitors" ; Boston University; Biomedical Engineering Department (2012)
• "Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem Cells" The Lung Epithelium in Health and Disease; FASEB (2012)
• "Efficient Derivation of Purified Nkx2-1+ Lung and Thyroid Progenitors via Directed Differentiation of Mouse ES Cells" 3rd International Conference on Stem Cell Engineering (ICSCE); Society for Biological Engineering (2012)
• "Towards an Artificial Lung" ERS 2011 Congress; ERS; Science Year in Review (2011)
• "Why should I pursue an academic career?" 6th Annual NIDDK Fellows Retreat; NIDDK (2011)

Service Activities:

• Wellcome Trust, Wellcome Career Development Awards; Reviewer (2023)
• French National Research Agency, “CE17 – Translational Research in Health” Panel; Reviewer (2023)
• 1st Annual JSMBS Community Research Day; Poster Session facilitator (2023)
• Medical Student Research Forum-Jacobs School of Medicine and Biomedical Sciences; Poster Judge (2023)
• National Institutes of Health/NHLBI, LIRR Scientific Review Group; Reviewer (2023)
• Dutch Research Council (NWO), The Netherlands; Reviewer (2022)
• Strategic Science Fund, Innovation Science and Economic Development, Government of Canada; Grant Reviewer (2022)
• 2021 Vermont biennial stem cell conference; Co-Chair (2021)
• ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies; Chair (2020–2022)
• ISCT 2020 Annual Meeting (Paris, France) Abstract Reviewer; Ad Hoc Reviewer (2020)
• ISCT 2020 Paris Virtual Conference “Emerging Issues in Unproven Cell Therapies” session organized by the ISCT Presidential Task Force (PTF) on the Use of Unproven and/or Unethical Cell & Gene Therapy (UCT), May 11 2020, ISCT 2020 Paris Virtual Conference.; Moderator (2020)
• Single Cell Sequencing Core, BU School of Medicine; Consultant (2020)
• ASCB/EMBO 2019 meeting (Washington DC) Abstract Programming Task Force; Ad Hoc Reviewer (2019)
• Program in Biomedical Sciences (PiBS), BU School of Medicine; Advisor (2019–2020)
• ISCT North America 2019 Regional Meeting "Regulatory aspects of Unproven Cell Therapies in North America” session organized by the ISCT Presidential Task Force (PTF) on the Use of Unproven and/or Unethical Cell & Gene Therapies (UCT), September 13 2019, ISCT North America 2019 Regional Meeting, September 13-15, 2019, Madison, WI; Moderator (2019)
• ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies; Co-Chair (2019–2020)
• 2019 Vermont biennial stem cell conference; Co-Chair (2019)
• 2019 Vermont biennial stem cell conference “Bringing Cell and Tissue‐Derived Products to Market: Regulation and Commercialization of Regenerative Medicine Products” session, July 17 2019; Moderator (2019)
• ISCT 2019 Annual Meeting (Melbourne, Australia); Ad Hoc Reviewer (2019)
• BU Genome Science Institute Single Cell Sequencing awards; Ad Hoc Reviewer for Program Grants (2019)
• Nano-Materials subcommittee, BUMC/CRC; Chair (2019–2020)
• ISCT 2018 European Union Regional Meeting (Florence, Italy); Ad Hoc Reviewer (2018)
• Cystic Fibrosis Foundation, Stem Cell 2017; Ad Hoc Reviewer for Program Grants (2017)
• 2017 Vermont biennial stem cell conference; Co-Chair (2017)
• 2017 Vermont biennial stem cell conference “Regulation of Stem Cell and Regenerative Medicine Treatments” session, July 26 2017; Moderator (2017)
• ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies; Member (2017–present)
• The Netherlands Organisation for Health Research and Development (ZonMw); Ad Hoc Reviewer for Program Grants (2017)
• FDA public hearing on Draft Guidances Relating to the Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ATS delegate at the FDA public hearing on Draft Guidances Relating to the Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products, September 12-13 2016, Bethesda, MD; Delegate (2016)
• Confocal Microscope Facility, BU School of Medicine; Advisory Committee (2016–2020)
• Protocol Standardization Committee, Center for Regenerative Medicine, BU/BMC; Chair (2016–2020)
• Nano-Materials subcommittee, BUMC/CRC; Committee Member (2016–2020)
• Cystic Fibrosis Foundation, Stem Cell 2015 - Research, Postdoc & P&F Study Section; Ad Hoc Reviewer for Program Grants (2015)
• Admissions Committee, Program in Biomedical Sciences (PiBS), BU School of Medicine; Committee Member (2015–2018)
• 2015 Vermont biennial stem cell conference; Organizing Committee Member (2015)
• Research Poster Session, Evans Research Days, BU School of Medicine; Judge (2014–2019)
• 2013 Vermont biennial stem cell conference; Organizing Committee Member (2013)
• American Thoracic Society Stem Cell Working Group Stem Cell Tourism monitoring activities; Coordinator (2013–2017)
• Lab Safety Committee, BUMC/CRC; Committee Member (2012–2020)
• American Thoracic Society Stem Cell Working Group; Member (2012–2017)
• Association of Greek NIH Postdoctoral Fellows; Coordinator (2004–2005)